Publications by authors named "Clara Compan"
Long-term quality of life after surgical Essure removal for device-attributed symptoms.
Eur J Obstet Gynecol Reprod Biol
January 2023
Article Synopsis
- The study looked at how patients felt after having their Essure devices surgically removed, checking their quality of life (QoL) and any symptoms they had before and after the surgery.
- 65 patients had the surgery, and while many felt better after 3 months and 4 years, some still had problems or didn't improve at all.
- The researchers found that mental health issues like anxiety were more common before the surgery but improved afterwards; they suggest more research to fully understand the risks and benefits of this surgery.
Background: Point-of-care testing (POCT) provides shorter turn-around times and, in many cases, potentially improves medical decision making. The AQT90 FLEX® benchtop immunoanalyzer (Radiometer Medical ApS, Copenhagen, Denmark) allows for the determination of beta-human chorionic gonadotropin (βhCG) in 18 min. The main aim of this study was to evaluate the impact of measuring βhCG using the AQT90 analyzer in the gynecology emergency department (ED) compared to the standard practice of using central laboratory blood testing on the patient length of stay (LOS).
View Article and Find Full Text PDFIntroduction And Hypothesis: The main objective of the study was to evaluate the rates of de novo stress urinary (SUI) and postoperative dyspareunia after both sacrocolpopexy/hysteropexy (SCP) and vaginal mesh surgery.
Methods: A prospective, multicenter, randomized, open-label study with two parallel groups treated by either SCP or Uphold Lite vaginal mesh was carried out. Study participants were ≥ 50 and < 80 years old patients with Pelvic Organ Prolapse Quantification (POP-Q) stage ≥2 who were considered eligible for reconstructive surgery and who were sexually active with no dyspareunia and free from bothersome SUI at presentation.
Article Synopsis
- * Included 95 women, who underwent various surgical procedures, and QoL was assessed using SF-36 questionnaires both before and three months after the surgery.
- * Results showed significant improvements in both physical and mental health scores post-surgery, indicating that most patients experienced a better quality of life three months after the removal procedure.
Background: Essure is an effective method for hysteroscopic sterilization. Reports of adverse effects, the underlying mechanisms of which are unknown, have increased in recent years.
Objective: The aim of the study was to determine whether there is a relationship between adverse events attributed to Essure and nickel sensitization.
Study Objective: To evaluate the feasibility, efficacy, and morbidity of Essure® device removal via laparoscopic en bloc salpingectomy-cornuectomy resection (LSC) and the utility of confirmation of complete removal with an intraoperative X-ray of the removed specimen (IX-S).
Design: Retrospective observational cohort study.
Setting: Academic hospitals of La Conception, Marseille, and Arnaud-de-Villeneuve, Montpellier, France.